BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37435496)

  • 1. Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy.
    Yang X; Zhang X; Shen K; Wang Z; Liu G; Huang K; He Z; Li Y; Hou Z; Lv S; Zhang C; Yang H; Liu S; Ke Y
    Front Pharmacol; 2023; 14():1033859. PubMed ID: 37435496
    [No Abstract]   [Full Text] [Related]  

  • 2. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.
    Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y
    Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity.
    Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W
    Front Genet; 2022; 13():939956. PubMed ID: 36105090
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
    Chen Y
    Front Genet; 2022; 13():912037. PubMed ID: 35937995
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of cuproptosis-related genes for predicting the development of prostate cancer.
    Wang X; Chen X; Xu C; Zhou W; Wu D
    Open Med (Wars); 2023; 18(1):20230717. PubMed ID: 37711156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of cuproptosis genes and cuproptosis-related genes as prognosis factors in esophageal squamous cell carcinoma.
    Wu Z; Huang Z; Zhou X; Gao C; Peng Z; Zheng X; Zhang Y; Du Z; Wu B
    Genomics; 2023 Nov; 115(6):110732. PubMed ID: 37866660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis.
    Ding D; Wang D; Qin Y
    Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and immuno-infiltration analysis of cuproptosis regulators in human spermatogenic dysfunction.
    Zhao M; Yu WX; Liu SJ; Deng YJ; Zhao ZW; Guo J; Gao QH
    Front Genet; 2023; 14():1115669. PubMed ID: 37065492
    [No Abstract]   [Full Text] [Related]  

  • 9. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.
    Bian Z; Fan R; Xie L
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas.
    Zhu H; Wan Q; Tan J; Ouyang H; Pan X; Li M; Zhao Y
    Front Genet; 2022; 13():992995. PubMed ID: 36579333
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of cuproptosis-related subtypes, characterization of immune microenvironment infiltration, and development of a prognosis model for osteoarthritis.
    Nong J; Lu G; Huang Y; Liu J; Chen L; Pan H; Xiong B
    Front Immunol; 2023; 14():1178794. PubMed ID: 37809099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma.
    Guo T; Zhang J; Yuan Z; Tang H; Wang T; Wang X; Chen S
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer.
    Zhou C; Li C; Zheng Y; Huang X
    Front Oncol; 2022; 12():934076. PubMed ID: 36387247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma.
    Chen Y; Zou X; Ma M; Liu Y; Wang R; Dai Z; Tashiheng Y; Yan Y; Yu X; Wang X; Liu C; Lin X; Cheng H
    Curr Oncol; 2023 Jan; 30(2):1648-1662. PubMed ID: 36826087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia.
    Li Y; Kan X
    Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia.
    Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N
    Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-cancer profiles of the cuproptosis gene set.
    Liu H
    Am J Cancer Res; 2022; 12(8):4074-4081. PubMed ID: 36119826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cuproptosis-related genes in prognosis and immune infiltration in grade 4 diffuse gliomas.
    Liu H; Bao X; Zeng Z; Liu W; Li M
    Heliyon; 2024 Apr; 10(7):e29212. PubMed ID: 38633656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 10 differentially expressed and cuproptosis-related genes in immune infiltration and prognosis of thyroid carcinoma.
    Yu W; Liu H; Zhang Y; Liu M; Li W; Wang L; Li D
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):89-94. PubMed ID: 38650151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma.
    Lv H; Liu X; Zeng X; Liu Y; Zhang C; Zhang Q; Xu J
    Front Pharmacol; 2022; 13():930041. PubMed ID: 35837286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.